Allscripts (MDRX) PT Raised to $16 at UBS
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Price: $4.95 -0.2%
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS raised its price target on Allscripts (NASDAQ: MDRX) to $16.00 (from $10.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
